Brainstorm Cell Therapeutics Inc.
September 28, 2023 - by Joey Ramson
$BCLI continues to fall. Down just over 50% on the day at the time of posting. Advisors to the U.S. Food and Drug Administration on Wednesday voted down the company’s investigational treatment for amyotrophic lateral sclerosis (ALS)
